COHBAR INC (CWBR) Stock Price, Quote, News and Overview
NASDAQ:CWBR - Nasdaq - US19249J3077 - Common Stock - Currency: USD
CWBR Quote, Performance and Key Statistics
0.761
-0.14 (-15.44%)
The current stock price of CWBR is 0.761 USD. In the past month the price decreased by -62.33%. In the past year, price decreased by -56.01%.
CWBR Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 19.97 | 357.10B | ||
| AMGN | AMGEN INC | 15.29 | 162.72B | ||
| GILD | GILEAD SCIENCES INC | 23.85 | 137.00B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 1669.79 | 124.40B | ||
| REGN | REGENERON PHARMACEUTICALS | 15.34 | 76.56B | ||
| ARGX | ARGENX SE - ADR | N/A | 39.16B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 32.32B | ||
| BNTX | BIONTECH SE-ADR | N/A | 28.77B | ||
| ONC | BEIGENE LTD-ADR | N/A | 27.25B | ||
| NTRA | NATERA INC | N/A | 21.43B | ||
| BIIB | BIOGEN INC | 8.54 | 20.49B | ||
| SMMT | SUMMIT THERAPEUTICS INC | N/A | 16.31B |
Related stock screener links
About CWBR
Company Profile
CohBar, Inc. is a clinical stage biotechnology company, which engages in the research and development of mitochondria-based therapeutics targeting chronic and age-related diseases. The company is headquartered in Menlo Park, California and currently employs 9 full-time employees. The company went IPO on 2015-01-06. The firm is focused on developing therapeutics targeting chronic and age-related diseases. Its processes of identifying nucleic acid sequences encoding native peptides in the mitochondrial genome, developing and optimizing novel analogs of these natural mitochondrial derived peptides (MDPs) and developing and conducting screens to identify and characterize the activities of these are referred to as its technology platform. Its advanced clinical candidate, CB4211, is a therapeutic for the treatment of nonalcoholic steatohepatitis and obesity. CB4211 demonstrated positive effects on reducing biomarkers of liver injury and improving metabolic homeostasis in a Phase 1a/1b clinical study in obese subjects with nonalcoholic fatty liver disease. CB4211 is a novel and improved analog of MOTS-c, a naturally occurring MDP. CB5138 Analogs are therapeutics that have demonstrated anti-fibrotic properties in a variety of preclinical models.
Company Info
COHBAR INC
1455 Adams Drive, Suite 2050
Menlo Park CALIFORNIA 94025 US
CEO: Steven Engle
Employees: 9
Company Website: https://www.cohbar.com/
Phone: 16504467888
COHBAR INC / CWBR FAQ
What is the stock price of COHBAR INC today?
The current stock price of CWBR is 0.761 USD. The price decreased by -15.44% in the last trading session.
What is the ticker symbol for COHBAR INC stock?
The exchange symbol of COHBAR INC is CWBR and it is listed on the Nasdaq exchange.
On which exchange is CWBR stock listed?
CWBR stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for COHBAR INC stock?
6 analysts have analysed CWBR and the average price target is 18.36 USD. This implies a price increase of 2312.61% is expected in the next year compared to the current price of 0.761. Check the COHBAR INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is COHBAR INC worth?
COHBAR INC (CWBR) has a market capitalization of 2.21M USD. This makes CWBR a Nano Cap stock.
How many employees does COHBAR INC have?
COHBAR INC (CWBR) currently has 9 employees.
Should I buy COHBAR INC (CWBR) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of CWBR, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of CWBR, evaluating the profitability, health, valuation and growth aspects
- COHBAR INC (CWBR) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- COHBAR INC (CWBR) Sales and EPS estimates to see what analysts future expectations are.
- COHBAR INC (CWBR) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- COHBAR INC (CWBR) Insider and Institutional Ownership to learn about the owners and their transactions.
- COHBAR INC (CWBR) Stock Chart to make your own analysis
- COHBAR INC (CWBR) Latest news and press-releases to stay up to date.
Does COHBAR INC (CWBR) stock pay dividends?
CWBR does not pay a dividend.
When does COHBAR INC (CWBR) report earnings?
COHBAR INC (CWBR) will report earnings on 2024-03-07, after the market close.
What is the Price/Earnings (PE) ratio of COHBAR INC (CWBR)?
COHBAR INC (CWBR) does not have a PE ratio as the earnings reported over the last twelve months were negative (-4.36).
CWBR Technical Analysis
CWBR Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to CWBR. CWBR scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
CWBR Financial Highlights
Over the last trailing twelve months CWBR reported a non-GAAP Earnings per Share(EPS) of -4.36. The EPS increased by 8.02% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -101.44% | ||
| ROE | -133.58% | ||
| Debt/Equity | 0 |
CWBR Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 43% to CWBR. The Buy consensus is the average rating of analysts ratings from 6 analysts.